FindTrial
Sign In

LEVOMEPROMAZINE

DRUG3 trials

Sponsors

Universitair Medisch Centrum Utrecht, Les Hopitaux Universitaires De Strasbourg, Hannover Medical School

Conditions

Anxiety DisordersDementiaDepressionPatient with a diagnosis of schizophrenia spectrum disorder (SSD): schizophreniaPsychosomatic DisordersSchizophreniaschizoaffective disorderschizoaffective disorder or brief psychotic episode according to DSM-5

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients
TerminatedNCT02374567
Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2
Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28
A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach
Not yet recruitingCTIS2023-509558-80-00
Les Hopitaux Universitaires De StrasbourgPatient with a diagnosis of schizophrenia spectrum disorder (SSD): schizophrenia, schizoaffective disorder or brief psychotic episode according to DSM-5, schizophreniform
Target: 288Updated: 2025-07-17

Phase 4

A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.
RecruitingCTIS2023-506602-39-00
Universitair Medisch Centrum Utrechtschizoaffective disorder, schizophrenia, schizophrenifom disorder
Start: 2024-08-01Target: 310Updated: 2025-03-04